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Abstract 
 
Objectives: Recovery of independent ambulation after stroke is a major goal. 
However, which rehabilitation regimen best benefits each individual is unknown and 
decisions are currently made on a subjective basis. Predictors of response to specific 
therapies would guide the type of therapy most appropriate for each patient. Although 
lesion topography is a strong predictor of upper limb response, walking involves more 
distributed functions.  Earlier studies that assessed the cortico-spinal tract (CST) were 
negative, suggesting other structures may be important. 
Experimental design: The relationship between lesion topography and response of 
walking speed to standard rehabilitation was assessed in 50 adult-onset patients using 
both volumetric measurement of CST lesion load and voxel-based lesion-symptom 
mapping (VLSM) to assess non-CST structures. Two functional mobility scales, the 
Functional Ambulation Category (FAC) and the Modified Rivermead Mobility Index 
(MRMI) were also administered. Performance measures were obtained both at entry 
into the study (3-42 days post-stroke) and at the end of a six-week therapy. Baseline 
score, age, time since stroke onset and white matter hyperintensities score were 
included as nuisance covariates in regression models.  
Principal observations: CST damage independently predicted response to 
therapy for FAC and MRMI, but not for Walk speed. However, using VLSM the 
latter was predicted by damage to the putamen, insula, external capsule and 
neighbouring white matter. 
Conclusions: Walk speed response to rehabilitation was affected by damage 
involving the putamen and neighbouring structures but not the CST, while the 
latter has modest but significant impact on everyday functions of general 
mobility and gait.  
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Introduction 
 
Around a third of stroke survivors are unable to ambulate 6 months after stroke 
(Alexander, et al., 2009), contributing a large portion of functional impairment and 
lost independence. Accordingly, rehabilitation aimed at recovering independent 
ambulation is an important part of post-stroke therapy, using various techniques that 
include apparatus-supported therapy such as treadmill exercise, balance activities and 
orthoses. However, the type of therapy that would best benefit each individual patient 
remains uncertain, and currently post-stroke therapy decisions are made on a 
subjective basis. Therefore, predictors of response to therapy, i.e., the gain in 
functional scores between baseline and final assessments, would be of considerable 
value in the clinical setting as they would point to the type and amount of therapy 
most effective in each individual. This would in turn maximise the effects of therapy 
and enhance recovery for each particular lesion type. 
 
Although previous studies have disagreed regarding the role of some clinical variables 
such as age, lesion volume and white matter small vessel lesion load as predictors of 
response to standard therapy (Burke, et al., 2014; Cramer, et al., 2007; Dawes, et al., 
2008; Dobkin, et al., 2014; Held, et al., 2012; Jorgensen, et al., 1995; Kollen, et al., 
2005; Lam, et al., 2010; Lindenberg, et al., 2012; O'Shea, et al., 2014; Stinear, et al., 
2007), time since stroke onset has been consistently found to influence, albeit weakly, 
response to rehabilitation therapy (Kollen, et al., 2005; Lam, et al., 2010; O'Shea, et 
al., 2014; Stinear, et al., 2007). Another, probably stronger clinical predictor is 
baseline impairment (Burke, et al., 2014; Cramer, et al., 2007; Dawes, et al., 2008; 
Dobkin, et al., 2014; Kollen, et al., 2005; Lindenberg, et al., 2012; O'Shea, et al., 
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2014; Riley, et al., 2011; Stinear, et al., 2007). However, lesion topography is 
generally considered the strongest potential predictor of response to therapy after 
stroke. 
 
Damage to the cortico-spinal tract (CST), and particularly to the portion of the CST 
originating from the primary motor cortex (M1), has consistently been reported as a 
major determinant of final outcome, including global impairment (Pineiro, et al., 
2000; Puig, et al., 2013; Puig, et al., 2011; Puig, et al., 2010) and particularly upper 
limb weakness (Feng, et al., 2015; Kim, et al., 2013; Lindenberg, et al., 2010; Lo, et 
al., 2010; Maraka, et al., 2014; Qiu, et al., 2011; Rosso, et al., 2013; Schaechter, et al., 
2009; Schulz, et al., 2012; Stinear, et al., 2007; Zhu, et al., 2010). However, 
information regarding how lesion topography affects walking outcome is scarce. As 
expected based on established CST neuroanatomy, in three studies leg weakness was 
significantly related to CST damage measured as involvement of the posterior limb of 
the internal capsule (PLIC) (Jayaram, et al., 2012; Lee, et al., 2005) or corona radiata 
(Alexander, et al., 2009), or overlap of the lesion with the whole extent of the CST 
(Jayaram, et al., 2012). However, walking and gait entail considerably more complex 
functions than just will-guided leg strength, and consequently are expected to involve 
more extensive systems than solely the CST (Perennou and Hillier, 2014). 
Accordingly, neither Jayaram et al nor Dawes et al found a significant 
relationship between lesion CST overlap and walking speed in the chronic stage 
post-stroke (Dawes, et al., 2008; Jayaram, et al., 2012). In one study the amount 
of CST damage predicted ambulation outcome assessed with the Functional 
ambulation category scale (Kim, et al., 2013), possibly suggesting a differential 
role of CST damage on walking   speed versus actual ambulation. Interestingly, 
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Alexander et al found that damage to the putamen, insula and external capsule was 
related to gait asymmetry (Alexander, et al., 2009), while abnormal activation of the 
basal ganglia, insula, secondary somatosensory area, or supplementary motor and 
premotor cortex during leg movement have also been found  associated with impaired 
lower limb movement (Dobkin, et al., 2004; Enzinger, et al., 2009; Mihara, et al., 
2012; Miyai, et al., 2003). Overall, therefore, other structures beyond the CST may be 
involved in walking impairment after stroke. 
 
Although as just described there is relatively abundant knowledge regarding the lesion 
anatomy of post-stroke motor impairment, particularly for the upper limb, much less 
is known of the predictive value of lesion topography for response to therapy, i.e., the 
change in clinical measures of motor deficit following participation in 
characterized rehabilitation intervention. Several studies have consistently 
reported that CST damage predicts response of upper limb motor deficit to therapy 
(Lindenberg, et al., 2012; Nouri and Cramer, 2011; Riley, et al., 2011; Stinear, et al., 
2007). In those studies, however, a substantial fraction of the variance in response to 
therapy remained unexplained, suggesting other systems are also involved. So far, two 
studies only have addressed the predictive value of CST damage for walking 
recovery. Both showed no significant relationship of CST lesion overlap (Burke, et 
al., 2014) (Dawes, et al., 2008), further suggesting that CST is not a strong 
determinant of recovery of walking speed, and that other structures are probably 
involved.   
 
In the present prospective study on a substantial sample of stroke survivors, we used 
volumetric CST lesion load measurement (Zhu, et al., 2010) to assess the relationship 
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between CST damage and response of walking speed to ambulation rehabilitation. In 
addition to specific CST damage volumetry, we also used voxel-based lesion-
symptom mapping (VLSM) (Bates, et al., 2003) to assess the role of non-CST 
structures. Finally, in addition to walk speed, two clinical scales measuring everyday 
mobility were also obtained.
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Subjects and Methods 
 
Patients  
Participants were prospectively recruited in the Soft-Scotch Walking Initial FooT 
(SWIFT) Cast randomised controlled trial. The trial evaluated the efficacy of 
augmenting conventional therapy, which could include standard ankle-foot orthoses, 
with a specific ankle-foot cast (SWIFT Cast) to enhance walking recovery (Pomeroy, 
et al., 2012). Only those patients who had agreed to undertake MR imaging, which 
was optional per protocol, were eligible for the present study. As the trial was 
completely neutral (Pomeroy, et al., 2015), both patient groups were merged for the 
analysis, as in two previous publications (Burke, et al., 2014; Cramer, et al., 2007). 
 
As detailed elsewhere (Pomeroy, et al., 2012), inclusion criteria were: aged 18+ years; 
3-42 days after stroke; infarct or haemorrhage; subjects in whom gait rehabilitation 
was judged both necessary and potentially useful, namely presence of gait 
abnormalities (knee hyperextension and/or abnormal initial floor contact) but able to 
take at least 3 steps while supported by two people; no contractures at hip, knee, ankle 
or forefoot or loss of skin integrity over the paretic foot/lower limb; able to follow a 
1-stage command i.e. sufficient communication/orientation for interventions in this 
trial; and otherwise physically fit for rehabilitation. Potentially eligible patients were 
enrolled into the study as soon as they were able to take at least 3 steps while 
supported by two people. Nature of the stroke (ie, ischemic or haemorrhagic) and 
ischemic stroke subtype (ie, large-vessel or lacunar) and topography were not part of 
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the inclusion criteria as the aim of the study was to recruit a sample as representative 
of patients referred for gait therapy to a rehabilitation unit as possible. 
 
The protocol was approved by the relevant Regional Ethics Committees and 
registered on a clinical trials database (ISRCTN 39201286).  Each participant gave 
signed informed consent. 
 
Clinical Assessment 
Functional performance measures were taken at entry into the study and the end of six 
weeks of intervention phase (Pomeroy, et al., 2012). The primary outcome measure 
was average walking speed (m.s
-1
). Walking speed was measured using a two-
dimensional light switch and video system which has good reliability (Ugbolue, et al., 
2013). Walking speed was chosen as the primary measure for the investigation of 
clinical efficacy as (a) it has international clinical utility; (b) was the target 
functional improvement for a SWIFT Cast; (c) is a meaningful functional 
outcome for stroke survivors; and (d) is used widely in stroke rehabilitation 
trials. 
 
In addition to walk speed, which is an objective metric for walking ability, two 
functional mobility scales that incorporate other factors than just motricity were 
obtained as secondary outcomes, namely the Functional Ambulation Category (FAC) 
and the Modified Rivermead Mobility Index (MRMI) (Lennon and Johnson, 2000). 
The FAC scale has six levels (Holden, et al., 1984) ranging from unable to walk 
(score 0) to able to walk independently (score 5), and includes components of balance 
and supporting use of the upper limbs for the scores up to 4. This measure has been 
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found to have strong inter-rater and test-retest reliability (Mehrholz, et al., 2007). The 
MRMI measures functional mobility across eight tasks including turning over in bed, 
sitting up from the lying position, sitting balance, transferring to a chair, sitting to 
standing, walking indoors and ascending stairs (Walsh, et al., 2010). Each MRMI task 
ranges from ‘unable to perform’ (score 0) to ‘independent’ (score 5). The amount and 
content of the physical therapy received by participants is described elsewhere 
(Pomeroy, et al., 2015).  The mean number of trial-specific rehabilitation sessions per 
participant was nine, with each session lasting a mean of 40 (SD 16) minutes over the 
six-week intervention phase.  
 
Given the aim of the present study to assess the anatomical predictors of response to 
therapy, the difference between the baseline and outcome measures for the three 
behavioural variables detailed above were calculated and used in all statistical 
analyses below, unless indicated otherwise.  
 
MR data acquisition 
The imaging substudy was part of the prospective trial design (Pomeroy, et al., 
2012), and aimed to address the question Does stroke location predict response to 
gait rehabilitation?, “predict” being used here in the statistical perspective, not 
at the individual subject level, ie, is there a location that correlates with response 
to therapy across the group? Patients who agreed to undergo scanning underwent 
structural MRI including a whole-brain ‘volume’ MPRAGE T1-weighted sequence 
and a T2-weighted FLAIR sequence (see below). In order to have an accurate 
delineation of the cerebral lesion, this session was undertaken three to eight weeks 
after stroke onset so that the lesion had stabilized (Gaudinski, et al., 2008), i.e. 
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without remaining swelling from oedema but before substantial shrinkage develops 
(Deoni, et al., 2008; Gale and Pearson, 2012). 
 
Scanning was performed at two recruiting centres using similar Siemens 1.5T 
scanners (Avanto and Magnetom Sonata, respectively). Whole-brain T1-weighted MR 
scans were acquired using a standard magnetization-prepared rapid acquisition 
gradient-echo (MPRAGE) sequence, which was followed by a standard whole-brain 
T2-weighted fluid-attenuated inversion recovery (FLAIR) sequence with  4 mm thick 
slices and 1 mm inter-slice gap. 
 
Lesion delineation 
Using MRIcron (www.cabiatl.com/mricro/index.html), the stroke lesion was 
delineated on FLAIR images (with help from the T1-MPRAGE images whenever 
appropriate) by a stroke neurologist with imaging experience (J-CB), blinded to all 
clinical data except the side of the stroke. In addition, white matter hyperintense 
lesions on FLAIR were rated according to the standard Fazekas scale, from 0 (absent) 
to 3 (maximum) (Fazekas, 1989). 
 
Image processing 
All image processing was performed in SPM8 (Wellcome Trust Centre for 
Neuroimaging, http://www.fil.ion.ucl.ac.uk/spm/software/spm8). The FLAIR images 
were coregistered to the T1 images and the T1 images were resliced to the FLAIR 
space. The lesions were smoothed using the SPM masking option of MRIcron 
(Rorden, et al., 2007) (http://www.cabiatl.com/mricro/mricro/mricro.html). T1 images 
were transformed into Montreal Neurological Institute (MNI) space using the unified 
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Segmentation and Warping process with lesion cost function masking (Andersen, et 
al., 2010; Brett, et al., 2001) and the transformation parameters were applied to the 
original lesions using nearest-neighbour interpolation to place the lesions in standard 
space. 
 
For the analyses described below, all right-sided lesions were flipped onto the left 
hemisphere to permit comparison across the whole group. 
 
Corticospinal tract (CST) lesion load 
The aim of this analysis was to assess the relationship between the amount of damage 
to the CST and the clinical measures across the patient sample. For each subject the 
probabilistic volume overlap of their lesion with the CST was computed according to 
the weighted-CST lesion load (wCST-LL) method (Zhu, et al., 2010). The wCST-LL 
was calculated by weighing each slice of overlap with the CST by the ratio of the 
maximum cross-sectional area of the CST over the cross-sectional area of that specific 
slice. This weighing option corrects for the narrowing of the CST descending into the 
PLIC from the motor cortex. In contrast to Zhu et al (2010), the canonical CST tract 
used in this study was determined by a probabilistic fiber tracing approach using FSL 
3.1.2 (http://www.fmrib.ox.ac.uk) and DTI data from 12 healthy elderly control 
subjects (9 male; mean age: 56.5 ± 14.8 years) (Feng, et al., 2015). Preprocessing 
steps included correction for eddy current effects, skull stripping as well as estimation 
and fitting of diffusion parameters. Single slice regions of interest (ROIs) were drawn 
on the FA images in the pons, PLIC, and the white matter underlying the posterior 
part of the precentral gyrus. Exclusion ROIs were drawn on the superior and medial 
cerebellar peduncle to exclude fibres to the cerebellum, as well as the middle sagittal 
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region covering the brain stem and corpus callosum to exclude trans-hemispheric 
fibers. Probtrackx (http://www.fmrib.ox.ac.uk/fsl/fdt/fdt_probtrackx.html) was used 
to track fibers from the pons ROI as the seeding region. Tracts were normalized to the 
SPM5 T2 template implemented in MATLAB (The Mathworks, Inc., Natick, MA), 
which was achieved by normalizing the DWI image to the SPM 5 T2 template, and 
then applying the normalization parameter to each CST tract. A 50
th
 fractional 
anisotropy percentile threshold was applied to each CST fiber, and then the twelve 
tracts were each binarized and summed to create the canonical CST. wCST-LL values 
obtained using this canonical CST significantly (p<0.0001) predicted 3-month Fugl-
Meyer (FM) (Fugl-Meyer, et al., 1975) upper extremity sensorimotor outcome in an 
unrelated dataset of 76 subjects (Feng, et al., 2015). Supplemental figure 1 illustrates 
the excellent coverage of motor fibers originating from the M1 leg area. 
 
VLSM 
VLSM was performed using vlsm2 version 2.53 (Bates, et al., 2003) 
(http://www.neuroling.arizona.edu/resources.html).  Each VLSM analysis identified 
clusters of voxels with statistically significant t-values comparing voxelwise subjects’ 
clinical measures with lesions to those without lesions, and identified a peak t-value 
within each significant cluster. Note that to avoid spurious results due to low numbers 
of lesioned voxels, only voxels lesioned in at least 6 participants were tested. The 
VLSM analysis involved first creating a t-value map showing voxels with 
greatest difference in responses to lesioned and unlesioned status, thresholded at 
an uncorrected default cut-off of p<0.005. In the second step, the confidence in 
this cluster was tested by permuting the subject data 5000 times, giving a 
distribution of clusters with a range of peak t-values. A cluster observed with the 
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first step was deemed significant at the p<0.05 level if its t-value was in the top 
5% of the clusters produced from randomly permuted data. The initial default 
cluster-forming threshold used was p<0.005. To correct for multiple comparisons the 
significance of the cluster was found by randomly permuting the measures 5,000 
times between subjects, i.e., non-parametrically. Only clusters with a peak t-values in 
the top 5% of those generated randomly were considered significant (p<0.05, 
permutation corrected).  
 
In order to determine as objectively as possible the anatomical structures involved by 
the significant clusters, the location of each cluster was labelled according to the 
Hammers atlas (Hammers, et al., 2003; Heckemann, et al., 2006) (www.brain-
development.org) for grey matter structures, the John Hopkins University (JHU) 
white-matter tracts atlas (Hua, et al., 2008), and where possible the Anatomy 
(Eickhoff, et al., 2005) atlas for Brodmann’s areas (BAs). We used the JHU tract atlas 
to assess the overlap of VLSM clusters with white matter tracts, including the CST. 
For each label, the percentage of the cluster overlapping with the given 
structure/tract/BA was obtained and tabulated.  
 
Statistical Analysis 
Clinical data: Descriptive statistics were used to present the clinical data and their 
inter-relationships. Continuous measures were summarized by mean and standard 
deviation or 95% Confidence Interval, and categorical data by median with 
interquartile range. Correlations were made using Kendall’s Tau; corrections for 
multiple tests were deemed unnecessary given the descriptive aim. Statistical analyses 
were performed in SPSS 21 (IBM SPSS Statistics for Windows, Version 21.0. 
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Armonk, NY: IBM Corp). Because a relatively large sample was used in this 
study, interpretation of the findings from correlations was not based only on the 
p value, which indicates the presence of a statistically significant relationship, 
but also on the r value, which assesses the strength of the relationship. In the 
present study we considered tau ≥ 0.6 to represent a strong relationship. 
 
 
wCST-LL analysis: the analysis of the relationship between wCST_LL and response 
to therapy for each of the three clinical scales was carried out with age, Fazekas score, 
time from stroke onset to baseline performance measures (to be referred to as “Time” 
below), and baseline score for the considered variable as added nuisance covariates. 
Lesion volume was not included as covariate as this can cause spurious results given 
the relationship between stroke size and topography according to vascular territories 
(Nachev, 2014). In addition, there was not even a trend of a correlation between 
lesion volume and response to therapy for any of the three clinical variables assessed 
(r range: 0.01-0.06, all p>0.53; data not shown). Multiple regressions were carried 
out for Walk speed and MRMI which are continuous and multiple categories 
variables, respectively, while for FAC, which has only five categories, ordinal 
regression was carried out. 
 
VLSM:  As with wCST-LL, all four covariates described above were added in the 
VLSM analysis for each of the three variables.
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Results 
 
Patient characteristics and behavioural scores 
Of the 105 trial participants, 56 consented to MR imaging but 4 were not suitable for 
inclusion in the image analysis (one had a hemi-craniectomy and another had marked 
hydrocephalus entailing marked brain distortion, one declined study approval after the 
MR session, and one had no visible lesion on MR), leaving 52 subjects with adequate 
MRI for the present study. Due to practical difficulties in obtaining MR slots for 
this research, some scans were carried out slightly later than expected (mean 
time of MR relative to stroke onset: 52 days; range 17-74 days), even sometimes 
a few days after end of therapy. Because outcome clinical scores were not 
available in two additional patients, the final analysis was on 50 subjects. 
 
Table 1 shows the patient demographics. The median time from stroke to enrolment 
in the trial was 16 days (range: 3-42 days), and for performance of MRI 52.9 days 
(SD: 11.8). This subset of 50 subjects did not significantly differ from the remaining 
53 trial subjects in any demographic or baseline clinical measure (data not shown). 
This material was made of 41 ischemic and 9 haemorrhagic strokes, of which 4 were 
hemispheric, 4 supratentorial deep-seated and one involved the brain-stem. Of the 
ischemic strokes, 22 were MCA-territory strokes (eight of which were purely deep-
seated and two associated with posterior cerebral artery infarction), two were anterior 
cerebral artery (ACA) strokes, one was an anterior choroidal artery stroke, and 16 
were lacunar infarcts (three of which located in the brainstem).   
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Table 2 shows the functional scores of the participants at baseline and six-week 
outcome, and the change from baseline to outcome. There was improved performance 
following treatment in all three functional measures, with average Walk Speed 
improving by 0.31m.s-1 (p<0.0001), MRMI by 10.06 (p<0.0001) and FAC by 2.42 
(p<0.0001).  
 
There were significant positive correlations regarding change in scores among all 
three clinical measures (all p<0.03), particularly between FAC and MRMI 
(p<0.001). However, they were weak between Walk speed and the other two 
scales (highest tau value: 0.386), while the tau value between MRMI and FAC was 
0.611, indicating that a large part of the variance remained unexplained. Accordingly, 
the wCST-LL and VLSM analyses were conducted for each variable separately, 
which also was justified by the marked differences in the everyday functions they 
assess (see Discussion).  
 
Table 3 shows the correlations of response to therapy for each behavioural measure 
with age, Fazekas score, Time and baseline score. Age significantly but weakly 
negatively affected FAC score change. Baseline score was a strong predictor of 
response of FAC and MRMI scores, but not for Walk Speed. The negative 
correlations indicated that the worse the initial score, the larger the absolute 
behavioural gain from therapy. Finally, Time significantly predicted score change for 
all three variables, again in the expected negative direction, but the correlations were 
weak.  
 
wCST lesion load analysis 
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One of the lesions was in the medulla and outside the standardised control CST, so 
this analysis was run on 49 subjects. Tables 4a, b, c show the results of the multiple 
regressions testing the correlation between the three response-to-therapy variables and 
wCST-LL adjusting for age, Fazekas score, Time and baseline score. Results from the 
multiple regrsssion analysis revealed that CST damage did not significantly predict 
Walk Speed change (p=0.60), but significantly impacted changes in both FAC and 
MRMI (p= 0.030 and 0.024, respectively), albeit not strongly so, in the negative, 
i.e., biologically expected direction. Baseline score had a strong influence on FAC 
and MRMI, but only a weak - albeit significant - influence on Walk speed. Time 
modestly but significantly influenced FAC and MRMI. Age significantly 
influenced FAC response only. Interestingly, Walk Speed was the least well predicted 
variable by the five covariates considered together.   
 
VLSM 
Figure 1 shows the lesion overlap map overlaid on a standard MNI space brain, 
documenting that the most common lesion site involved the striato-capsular area. Out 
of the 50 subjects, four lesions had no overlap with any of the other lesions and the 
maximum number of overlapping lesions was 24. Supplemental Figure 2 shows the 
overlap for voxels lesioned in at least 6 subjects, i.e., the ‘search volume’ for the 
VLSM analysis. This illustrates that the striato-capsular area, the frontal white matter 
up to the centrum semi-ovale, the external capsule, the insular cortex and extensive 
cortical areas including the precentral gyrus and the frontal opercula were all 
encompassed in the search volume. A power map from the lesion overlaps with the 
zero-thresholded left corticospinal tract (CST) overlaid from the John Hopkins 
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University (JHU) white-matter tracts atlas is shown in Supplemental Figure 3, 
illustrating that the CST intersects close to the peak power area.  
 
According to a design that included age, Fazekas scores, Time and baseline scores as 
nuisance covariates, the VLSM analysis revealed a single significant cluster for Walk 
Speed response to therapy, with a p value <0.02. Lesion in this area was significantly 
correlated with poorer recovery. Table 5 labels the cluster’s centre of mass in MNI 
space, together with the percentage of the cluster labelled according to the Hammers 
and JHU white-matter tracts atlases. The overlaps with the Anatomy are not shown 
because the cluster did not overlap with any Brodmann area identified in this atlas. 
Figure 2 depicts this cluster overlaid on a standard MNI template. The areas 
encompassed included the insula, lateral and anterior putamen and external capsule, 
and the superior longitudinal, inferior fronto-occipital and uncinate fasciculi. Of note, 
the cluster did not overlap with the CST. There were no significant findings with FAC 
or MRMI.  
 
Discussion 
 
To our knowledge this is the first study to combine CST damage measurement and 
VLSM to comprehensively assess the relationship between lesion topography and 
clinical measures of motricity post-stroke. To this end, we used the wCST-LL 
method (Feng, et al., 2015; Zhu, et al., 2010) and VLSM (Bates, et al., 2003) to 
assess the role of CST and non-CST damage, respectively. Because the former 
assesses the CST in its entire intracranial length rather than locally as the latter 
does, it is expected to have much greater sensitivity and accuracy to assess the 
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role of CST lesion in behavioral outcome. Our specific goal using this 
complementary approach was to investigate whether lesion anatomy predicts the 
response of stroke-induced impaired walking and mobility to rehabilitation. One 
strength of our study is the use of three different outcome measures, namely 
walk speed as primary outcome, and FAC and MRMI, two functional scales 
assessing distinct daily functions - namely getting out of bed and ambulating, and 
walking under various environments, respectively - as secondary measures. A 
final strength is the substantial sample size available, affording adequate statistical 
power. 
 
General points 
Before discussing the results, it is worth clarifying from the outset that our aim was 
not to decipher the mechanisms underlying recovery of walking after stroke, but to 
determine if stroke lesion topography predicts response to gait rehabilitation. We 
addressed the following pragmatic clinical question: Can response to gait therapy be 
predicted based on stroke lesion topography as determined on standard clinical MRI? 
Accordingly, we did not assess variables such as functional activation patterns, 
functional and structural connectivity changes, white matter tract degeneration or 
structural changes remote from the lesion such as enlarged cortical thickness or white 
matter bundles, that all can underlie plastic processes and hence contribute, or 
impede, functional recovery (Calautti and Baron, 2003; Cramer, 2008; Johansen-
Berg, et al., 2002; Sharma, et al., 2009). Although these MR-based investigations 
would be of interest to decipher the mechanisms underlying recovery of walking post-
stroke, they would not contribute to our pragmatic and directly clinical aim.  
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Three main results emerged from our study. First, baseline scores and time to baseline 
assessment, and less consistently age, predicted response to therapy for some or all 
clinical variables, confirming these are important covariates to consider when 
assessing the independent predictive value of lesion topography for behavioral gains. 
Second, using a multiple regression model accounting for the above covariates plus 
white matter lesion score, CST damage independently influenced FAC and MRMI 
response, but not Walk speed. Importantly, of the three clinical measures, Walk 
Speed response was the least well predicted by the five-variable model, suggesting 
other variables are operative. Accordingly, assessing non-CST lesion involvement 
using VLSM revealed significant findings only for Walk Speed, namely a cluster 
involving the insula, putamen, external capsule and surrounding white matter tracts.    
 
The findings regarding the covariates deserve a brief comment. Baseline score had the 
strongest influence, consistent with previous studies on post-stroke walking and 
ambulation (Burke, et al., 2014; Dawes, et al., 2008; Jorgensen, et al., 1995; Kollen, et 
al., 2005). That time elapsed since stroke onset also influenced response to therapy 
was expected given that this study enrolled patients relatively early after stroke, and 
that recovery is steeper at the early post-stroke stage (Duncan, et al., 1992). Previous 
studies carried out in the chronic stage also reported an effect of time on recovery 
(Kollen, et al., 2005; O'Shea, et al., 2014; Stinear, et al., 2007). Again consistent with 
previous work (Dobkin, et al., 2014; Held, et al., 2012; Jorgensen, et al., 1995; Lam, 
et al., 2010; Stinear, et al., 2007), age impacted – albeit weakly so – recovery of 
ambulation. Finally, white matter FLAIR hyperintense lesion load did not 
significantly influence recovery, but was included a priori in the model given its 
previously reported impact (Held, et al., 2012). 
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Involvement of the CST 
CST damage independently, albeit weakly, predicted FAC and MRMI response 
to therapy, but not Walk Speed. This limited impact of CST damage on gait and 
ambulation recovery may seem unexpected given the reports regarding the upper limb 
consistently showing a strong effect (Lindenberg, et al., 2012; Nouri and Cramer, 
2011; Riley, et al., 2011; Stinear, et al., 2007). It is unlikely that our findings are due 
to inadequate power, since the sample size was similar to that analyzed in a previous 
upper limb impairment study also using wCST-LL (Zhu, et al., 2010), and several-
fold larger than three positive studies of upper limb response to therapy (Lindenberg, 
et al., 2012; Riley, et al., 2011; Stinear, et al., 2007) that all showed a significant role 
of the CST. Our findings are in fact entirely consistent with a previous study that 
reported that CST damage predicted ambulation outcome assessed with FAC 
(Kim, et al., 2013), as well as with all previous reports that assessed the role of 
CST damage in walk speed outcome (Jayaram, et al., 2012) or response to 
therapy (Burke, et al., 2014; Dawes, et al., 2008), which were all negative. 
 
Previous work, also using the wCST-LL method, found that within the same 
population of stroke survivors, CST damage was more strongly related to upper limb 
than lower limb sensorimotor function (assessed with the Fugl-Meyer scale) (G. 
Schlaug et al, unpublished data). The weaker predictive value of CST damage for 
lower compared to upper extremity outcome might in part reflect the fact that 
canonical CST templates do not include other descending corticospinal tracts such as 
the corticorubral and the corticotegmental spinal tracts, which have slight differences 
in their cortical origins compared to the pyramidal tract (Ruber, et al., 2013; Ruber, et 
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al., 2012) and might innervate alpha motoneurons on both sides of the spinal cord, 
either directly or indirectly, as well as proximal muscles more than distal muscles. As 
compared to upper extremity sensorimotor function, walking involves quite different 
motor control processes, including adapted body orientation relative to space and 
environment, trunk stabilization around the body’s centre of mass, generation of 
alternate leg force to produce a cycling movement, and secure navigation in the 
surroundings (Perennou and Hillier, 2014), which might account for a limited role of 
the CST, and an important role for other structures, in this largely automatic function. 
Conversely, that CST damage influenced FAC and MRMI may reflect the more 
composite nature of these scales that involve ‘cortical effort’, as they for instance 
include on top of walking help with the upper limbs and trunk mobility, and are 
assessed in real, complex environment such as bed surroundings or stairs.  
 
Involvement of other structures 
Given the lack of impact of CST damage on Walk Speed response, and the 
limited impact of the clinical variables tested, the finding that a non-CST located 
cluster emerged from VLSM is not unexpected. Based on VLSM, involvement of 
the insula, lateral and anterior putamen and external capsule hindered Walk Speed 
response, independently of the other covariates. Note that the percentages for lesion 
overlap shown in Table 5 are only approximate because the Hammer’s Atlas 
focuses on gray matter structures and does not consider fine anatomical details. 
This is particularly true for the “insula” label, which encompasses also the 
external capsule, claustrum and extreme capsule, leading to gross overestimation 
of the overlap with the insula proper. Note also that the VLSM cluster did not 
overlap with the areas of highest statistical power (Supplemental Figure 3), 
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which involve the deep white matter and CST regions, and hence is not the result 
of intrinsic bias. In addition, the permutation analysis was carried out on the 
whole search area, not just on the voxels selected by the initial first-level 
thresholding, i.e., there was no circularity or ‘double-dipping’ involved 
(Kriegeskorte, et al., 2009). It is standard in VLSM studies to consider 
correlations that survive this extremely stringent process as very robust. 
 
 
The putamen, as a node in the subcortico-cortical motor loop, is involved in 
movement initiation, which is impaired in Parkinson’s disease (Alexander, et al., 
1990; DeLong and Wichmann, 2007), and involved in the implicit learning and 
execution of well-learned sequences (i.e. procedural memory) including walking and 
balance, accounting for its apparent role in re-learning to walk after stroke (Scherder, 
et al., 2011). It is therefore not surprising that damage to the putamen impairs the 
automatic act of walking. Previously, Alexander and colleagues reported an 
association of gait asymmetry and leg weakness to lesions of the lateral putamen, 
external capsule and insula in partly recovered stroke patients (Figure 2A in 
(Alexander, et al., 2009)). Also, changes in putaminal fMRI activations during foot 
movement were found to correlate well with improvements in walking speed 
following treadmill-based rehabilitation after stroke (Enzinger, et al., 2009). Using 
VLSM, Wu et al recently reported that the putamen, insula and external capsule, 
among other structures, contribute to poor functional outcome post-stroke (Wu, 
et al., 2015), and Cheng et al found that lesions to the insula affected global 
outcome (Cheng, et al., 2014). Overall, therefore, our finding that damage to the 
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putamen, insula and external capsule affects recovery of walking is consistent with 
previous work.  
 
The VLSM analysis also suggested that damage to the superior longitudinal, inferior 
fronto-occipital and uncinate fasciculi affected Walk Speed response. The functions 
sustained by the two former tracts are not well understood, but they connect the 
prefrontal and premotor regions to the occipital cortex, and as such could be involved 
in balance and walking. Accordingly, white matter ischemic lesions particularly 
involving the frontal lobe are associated with  gait impairment (de Laat, et al., 2011). 
More specifically, damage to the superior longitudinal fasciculus has been linked to 
decreased postural stability and wide-based gait in elderly subjects (Scherder, et al., 
2011). Regarding the uncinate fasciculus, which connects the anterior part of the 
frontal lobe to the medial and lateral temporal cortex, its damage in aged people has 
been linked to decreased step length and walking velocity as well as more generally 
with apractic gait (Scherder, et al., 2011).  Following a stroke, damage to the 
superior longitudinal and uncinate fasciculi were recently reported to contribute 
to worse global functional outcome (Wu, et al., 2015).   
 
On a physiological standpoint, although the hard-wired basis for synergistic 
stepping is engendered in the spinal cord by so-called ‘central pattern 
generators’ (CPGs), walking involves a variety of supraspinal areas. Current 
understanding proposes that supraspinal control may in fact be more important 
than CPGs for human walking (reviewed by (Verma, et al., 2012). Evidence for 
this interpretation includes the association of gait temporal asymmetry after 
stroke with posterolateral putamen lesion (Alexander, et al., 2009). More 
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recently, it has also been shown that, together with the pedunculopontine nucleus 
located in the brainstem, the sub-thalamic nucleus, which is part of Alexander’s 
motor loop referred to above and as such strongly connected to the putamen and 
motor cortical areas, plays a significant role in imagined gait in humans (Lau, et 
al., 2015). 
 
Stroke side 
In order to ensure optimal statistical power, lesions were flipped so that they all 
mapped onto the same hemisphere, as is widely done (Cheng, et al., 2014; Lo, et al., 
2010; Zhu, et al., 2010). However, half of the patients had their stroke on either side. 
Although there is only scant evidence that ambulatory functions are hemisphere-
dependent, this hypothesis cannot be excluded. To address this we repeated post-hoc 
the VLSM analysis separately for the left and right-sided strokes (n=26 in each), 
which revealed no significant cluster for either (data not shown), likely from the loss 
of statistical power.  
 
Mobility, ambulation and walk speed 
In the present study we used three different measures of recovery, namely Walk 
Speed as primary outcome, and FAC and MRMI as secondary measures. 
Although response to therapy for these three scales was significantly inter-
correlated, the correlations between Walk Speed and the other two scales were 
weak, while that between FAC and MRMI was strong but accounted for only 
~50% of the variance, in part reflecting the fact that these two scales share some 
items (eg, walking independently). However they are constructed to assess 
different everyday functions, i.e., MRMI assesses the ability to move in and get 
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out of bed and walk, and includes items such as turning over in bed, lying to 
sitting, sitting balance, sitting to standing, standing balance, walking indoors and 
walking up the stairs, while FAC assesses ambulation in various surroundings 
including in parallel bars, evaluating the degree of dependency on physical 
assistance right through to independence. Accordingly, although their 
relationships with wCST-LL and several co-variates are similar (Tables 4b and 
c), their relationship with age is different, and differences between MRMI and 
FAC vs Walk Speed (Table 4a) are even more striking. On a clinical point of 
view it would have no relevance to merge MRMI and FAC into a single 
compound variable because they are validated and used in whole in daily 
rehabilitation practice, while Walk Speed represents speed of walking in a 
laboratory setting (ie, walking forwards on a flat, even floor, in a protected 
environment). These three scales were prospectively chosen for this study for 
these specific reasons. Likewise, it would not be clinically acceptable to split 
these scales into their component items with a view to derive independent 
dimensions, because they have been prospectively constructed to represent a 
single overall everyday function (e.g., getting out of bed and ambulate, as at 
home) and then validated as a single value in extensive investigations.  
   
Limitations 
Stroke topography varied widely across patients in our sample (Supplemental Fig 2), 
which could have increased the variance and reduced the statistical strength of this 
study despite the sizeable sample. However, our sample was gathered prospectively 
among consecutive referrals to rehabilitation centers, as part of a randomized clinical 
trial. Accordingly, our sample is representative of routine referrals for post-stroke gait 
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rehabilitation, making our results clinically relevant. Selecting post hoc a 
homogeneous sub-sample based on e.g., stroke topography or etiology would have 
hindered this clinical relevance and generalizability. On the other hand, this 
variability caused the VLSM search volume to be restricted to a circumscribed zone 
(Figure 2). Of note, the M1 leg area, which is located on the medial surface of the 
posterior frontal lobe and belongs to the ACA territory, was not part of the search 
volume, so the influence of its lesion on treatment response could not be assessed. 
However, consistent with the notion that ACA infarctions are relatively rare, 
individual analysis of native space MRI showed only 2 patients with leg area 
involvement, and this was in fact associated in both cases with extensive subcortical 
damage (Supplemental Figure 2). 
 
Applying VLSM requires that a minimum number of subjects with a lesion in any 
particular voxel be set a priori, simply because the statistical analysis is based on two-
sample comparisons and the ‘lesioned’ sample has to be reasonably large to make 
robust inferences. Although there is no strict recommendation on how to determine 
this threshold in each particular study, we used six subjects in the present study 
because this is a statistically reasonable sample. In order to further explore this issue, 
we carried out a post-hoc sensitivity analysis using 10 subjects as threshold. The same 
cluster as with six subjects emerged, although as expected smaller. We also carried 
out additional post-hoc sensitivity analyses using <0.001 as initial default p threshold. 
Again the same cluster emerged, of smaller extent but including the same anatomical 
structures. The same was true using a threshold of 10 subjects and p<0.001 as initial 
default. These sensitivity analyses therefore strongly support the robustness of our 
VLSM findings.  Regarding the topographical accuracy of VLSM, it has been argued 
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that studying patients with large-artery ischemic strokes might cause several-mm 
displacement of the significant clusters because of the intrinsic vascular architecture 
affecting the shape of resulting infarcts (Mah, et al., 2014). In this situation, distinct 
approaches to image processing requiring very large datasets and simple, 
dichotomized outcomes have been proposed (Mah, et al., 2014). However, the present 
study enrolled patients with highly variable stroke mechanisms (including 9 with 
haemorrhage) and infarct locations and etiologies (including 17 with lacunar infarcts), 
which would have mitigated any such effect. Minor errors in the precise anatomical 
localisation of the VLSM cluster cannot however be excluded.  
 
We do not provide formal validation of our findings in two independent samples. 
Given that the maximum number of patients with a lesion in any given voxel was 
24 (Figure 1), it was not feasible to split the sample in two to assess 
reproducibility with adequate power. We have however carried out an internal 
validation of the VLSM cluster using the ‘leave-one-out’ approach, which 
showed a stable peak location (center of mass within 1.4mm of whole group 
cluster for 48/50 analyses). Nevertheless, replicability of our findings is an 
important goal for future studies. Finally, although we identify regions that may 
help predict treatment response, we do not claim that we can individually 
classify responders according to lesion location. To be able to do this and for 
instance report sensitivity and specificity, dichotomized classification of response 
to therapy as responders and non-responders would be required.  However, 
there is no universally accepted, validated dichotomized Walk Speed, FAC or 
MRMI response available at this time. 
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This study was carried out as part of a pragmatic randomised trial assessing whether 
the benefits of routine physical therapy could be augmented by an ankle-foot orthosis 
(AFO), custom-made and fitted by a therapist within a 24-hour period, to provide 
optimal alignment of the lower limb to the ground during walking (Pomeroy, et al., 
2012). Thus both groups received routine physical therapy (‘treatment-as-usual’) 
provided by the clinical physiotherapists. As presented in detail elsewhere 
(Pomeroy, et al., 2015), there were no statistically significant differences between the 
two groups in the content of physical therapy they received, except that the control 
group had higher use of off-the-shelf AFOs and the experimental group had as 
expected a higher use of a SWIFT Cast, and there were no statistically significant 
differences between the groups for any outcome measure, not even evidence of trends 
(Pomeroy et al submitted). The experimental device therefore did not influence 
response to therapy, and our findings are therefore applicable to standard physical 
therapy in routine clinical practice.    
 
In our study there was a wide variance in the nominal number of sessions given 
to and treatment duration among patients (Pomeroy, et al., 2015), which could 
have influenced response to therapy. However this was a pragmatic trial 
conducted in the routine rehabilitation environment where participants were 
resident either a hospital stroke rehabilitation ward or their own homes. As is 
commonplace in similar trials, the study could not make it compulsory for 
therapists to record in a systematic and standardized way each and every minute 
of routine therapy directed at enhancement of lower limb function they gave to 
the participants of the trial. Thus the data collected is for therapy provided when 
a therapist was present and does not include any additional, self-administered 
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therapy. Consequently, the data was judged insufficiently accurate to be used as 
a covariate. Nevertheless, applying standard methods for missing data in the 
present MRI subset, we found no significant relationship between treatment 
duration and response to therapy for any of the three clinical measures (data not 
shown). This is in fact not surprising as there is no clear relationship between the 
amount of standard post-stroke physiotherapy and clinical response (English 
and Veerbeek, 2015), partly because more disabled subjects tend to get more 
intensive therapy, whilst less affected subjects are trained and instructed to 
recourse to self-administered walking and balance exercises. Despite the above 
caveats, we tested the effects of adding treatment duration as a further covariate 
in the multivariate analyses, which did not substantially change the results of the 
wCST-LL analyses and VLSM. 
 
In our study the MRI was carried out only after recruitment and start of 
therapy. This was considered unimportant for the assessment of the predictive 
value of stroke lesion location for response to therapy because stroke lesions are 
stable from about two weeks after onset (after vasogenic edema has vanished) up 
to around 12 weeks (before significant shrinkage occurs) (Gaudinski, et al., 
2008). Because of difficulties in obtaining scanning slots for this research study, 
some scans were carried out slightly later than planned, which could have 
affected the accuracy of lesion masks in some cases. In the event of real-life 
application of our paradigm, however, MR scanning would need to be carried 
out before the rehabilitation regimen is decided, in order to guide it. In the 
clinical setting, if MRI is not available other approaches to predict response of 
walking speed to gait therapy could be considered such as TMS (Hendricks, et 
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al., 2003a; Hendricks, et al., 2003b; Piron, et al., 2005), which however does not 
provide information regarding non-CST located damage.  
 
Conclusion 
The findings from the present study suggest that strokes affecting the lateral putamen 
and neighbouring structures reduce response of walking speed to standard 
rehabilitation, while cortico-spinal tract damage has statistically significant, 
though somewhat limited, impact on two functional scales assessing general 
mobility and gait.  
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Table 1. Baseline characteristics of the subjects (N=50) showing showing median 
(interquartile range) and range unless otherwise stated 
 
  
Male/Female 28/22 
Left/Right 25/25 
Infarct/Haemorrhage 41/9 
Age (years) 64.6 (15.0)†, 27-100 
Time to Baseline assessment (days) 16.0 (9-25), 3-42 
Fazekas score 2 (1-2), 0-3 
Lesion Volume (cm3) 4.4 (0.8-28.1), 0.05-188.18 
 
 
† Mean (SD). 
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Table 2. Summary functional performance measure (median and interquartile range 
unless otherwise stated; N= 50) 
 Baseline Outcome 
 
Change Effect 
 size 
p-
value& 
Walk Speed (m/s) 0.00 (.00-.25) 0.49 (.18-
.71) 
0.24 (.00-.51) 0.69  <0.000 
MRMI 24 (19-32) 37 (34-38) 10 (4-15) 0.73 <0.000 
FAC 1 (0-2) 4 (4-4) 3 (1-4) 0.58 <0.000 
FAC = Functional Ambulation Category; MRMI = Modified Rivermead Mobility 
Index. Change means the difference between Outcome and Baseline, i.e. response to 
therapy. Effect sizes are from Cohen’s r
2
 = Wilcoxon  .  Cohen’s d 0.2-0.5 = 
small effect size ~= r2 0.01-0.06; 0.5-0.8 = medium effect size ~= r2 0.06-0.17; >0.17 
= large effect size. &: Wilcoxon signed rank test. 
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Table 3. Correlation of Response to Therapy for the three behavioural measures with 
four baseline variables (Kendall’s Tau) 
 
 
 
 
Age (years) Fazekas 
Score 
Baseline Score Time from   
Stroke to 
Baseline 
Walk Speed 
-0.19 (p=0.06) -0.18 (p=0.10) -0.21 (p=0.07) -0.23 (p<0.03) 
FAC 
-0.25 (p<0.02) -0.04 (p=0.76) -0.60 (p<0.001) -0.26 (p<0.02) 
MRMI 
-0.11 (p=0.29) 0.01 (p=0.91) -0.65 (p<0.001) -0.26 (p<0.01) 
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Table 4a. Multiple Regressions to predict Walk Speed response to therapy (N = 49 
subjects)† 
 
    β Standard 
Error 
   Standardized  
    β coefficients 
Partial r  p Pearson r 
wCST-LL -0.007 0.014     -0.085 -0.079 0.606 -0.004 
Age -0.002 0.003     -0.108 -0.100 0.512 -0.247 
Fazekas Score -0.060 0.050     -0.193 -0.180 0.236 -0.262 
Baseline score -0.376 0.185     -0.274 -0.296* 0.049 -0.295 
Time -0.006 0.004     -0.249 -0.250 0.098 -0.327 
†Response to therapy as dependent variable from a multiple regression with predictors wCST 
load, age, Fazekas score, baseline Walk Speed, and Time. For each variable, the Βeta, standard 
error for Βeta, and standardized Βeta Coefficient is given together with the significance for this 
component, the raw Pearson correlation of the dependant variable with response to therapy, 
and the partial correlation independently of other variables.*: p<0.05. 
 
Table 4b. Ordinal Regression to predict FAC response to therapy§ 
 OR 95% CI Wald χ
2
(1) p-value Pearson r 
wCST-LL 0.80 0.66-0.98 4.71 0.030* -0.155 
Age 0.94 0.89-0.98 6.78 0.009* -0.302* 
Fazekas Score 1.29 0.64-2.60 0.50 0.478 -0.046 
Baseline score 0.21 0.11-0.38 25.54 0.000** -0.658** 
Time 0.94 0.89-1.00 4.37 0.037* -0.331* 
§Response to therapy as dependent variable from an ordinal regression with predictors wCST 
load, age, Fazekas score, baseline Walk Speed, and Time. For each variable, the Odds Ratio 
(OR), 95% Confidence Interval for the OR, and the χ2 is given together with its significance for 
this component, and the raw Pearson correlation of the dependant variable with response to 
therapy. *significant p<0.05, ** p<0.001. The OR for Age implies the odds of recovery 
decrease by 0.94 for each increase in age of one year. Units for Time to Baseline are days, and 
wCST cm3. 
 
Table 4c. Multiple Regressions to predict MRMI response to therapy (same explanations as Table 
4a) 
     β Standard 
Error 
Standardized  
β coefficients 
Partial r   p Pearson r 
wCST-LL -0.489 0.209 -0.241 -0.335* 0.024 -0.195 
Age -0.079 0.049 -0.168 -0.241 0.111 -0.125 
Fazekas Score  0.382 0.768  0.051 -0.076 0.621   0.001 
Baseline score -0.701 0.081 -0.740 -0.798** 0.000 -0.752* 
Time  -0.133 0.058 -0.215 -0.330* 0.027 -0.369* 
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Table 5. Significant cluster from the VLSM analysis of Walk Speed response to therapy, obtained from a design 
including age, Fazekas score, baseline Walk Speed and time from stroke to baseline assessment as nuisance 
covariates (see Methods). Clusters are anatomically labelled by the Hammers and John Hopkins University 
white-matter label tracts (JHU) atlases (rounded % of overlap in brackets). Only overlaps ≥1% are listed. 
*Cluster size in voxels (corresponds to a volume of 2.47ml); $: MNI coordinates; †: p value (p<0.05 
FWE following uncorrected threshold of p<0.005; see Methods) 
 
 Cluster 
size* 
  Centre  
 of mass
$ 
  p† Hammers (anatomy) JHU (white matter tracts) 
Walk 
Speed 
309 
 
[-30,5,4] 
 
<0.02 Insula (67) 
Putamen (27) 
Middle frontal gyrus (3) 
 
Inferior fronto-occipital fasciculus (28) 
Superior longitudinal fasciculus (24) 
Uncinate fasciculus (14) 
Anterior thalamic radiation (3) 
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Figure Legends 
 
Figure 1. Lesion overlap map from the 50 participants overlaid on a standard MNI 
space brain after the right-sided lesions had been flipped to the left side (see 
Methods), and projected onto the whole set of axial slices from the canonical normal 
subject T1-weighted MRI in Montreal Neurological Institute (MNI) space.  The 
number of participants in each pixel is shown on the pseudo-colour scale on the right. 
The maximum number of participants with a lesion for any voxel was 24 (red colour) 
and involved the striato-capsular area and corona radiata. 
 
Figure 2. Significant VLSM cluster (yellow) showing lesioned voxels negatively 
correlated with Walk Speed response to therapy, projected onto the MNI canonical 
T1-weighted MRI (see Fig 1 for details). Only the axial slices with significant voxels 
are presented (the figure above each slice is the z coordinate in mm in MNI space). 
Statistical significance was determined following permutation correction at p<0.05 
FWE correction for multiple comparisons, and controlling for age, Fazekas score, 
time since stroke onset and baseline Walk Speed score as nuisance covariates in the 
multivariate model (see Methods). See Table 5 for coordinates, p value and 
anatomical location of the cluster. The canonical JHU corticospinal tract (blue) did 
not overlap with the cluster.  
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Supplemental Figure legends 
  
Supplemental Figure 1: Selected coronal, axial and sagittal sections in normalized 
MNI space of the canonical CST tract used in this study for wCST-LL calculations, 
illustrating it encompasses the CST fibers originating from the primary motor cortex 
leg area. 
 
Supplemental Figure 2: Lesion overlap map with a minimum of 6 participants with 
lesion for each particular pixel (same presentation as Figure 1). The coloured area 
therefore represents the search volume for the VLSM analysis (see Methods).  
 
Supplemental Figure 3: Power map from the lesion overlaps with the zero-
thresholded corticospinal tract overlaid (blue). Note that the tract intersects close to 
the peak overlap. See Figure 1 for details regarding presentation. Power is represented 
as the probability of detecting an effect at the p<0.05 level  for the distribution of 50 
lesions. 
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Figure 1. Lesion overlap map from the 50 participants overlaid on a standard MNI space brain after the 
right-sided lesions had been flipped to the left side (see Methods), and projected onto the whole set of axial 
slices from the canonical normal subject T1-weighted MRI in Montreal Neurological Institute (MNI) 
space.  The number of participants in each pixel is shown on the pseudo-colour scale on the right. The 
maximum number of participants with a lesion for any voxel was 24 (red colour) and involved the striato-
capsular area and corona radiata.  
140x204mm (300 x 300 DPI)  
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Significant VLSM cluster (yellow) showing lesioned voxels negatively correlated with Walk Speed response to 
therapy, projected onto the MNI canonical T1-weighted MRI (see Fig 1 for details). Only the axial slices with 
significant voxels are presented (the figure above each slice is the z coordinate in mm in MNI space). 
Statistical significance was determined following permutation correction at p<0.05 FWE correction for 
multiple comparisons, and controlling for age, Fazekas score, time since stroke onset and baseline Walk 
Speed score as nuisance covariates in the multivariate model (see Methods). See Table 5 for coordinates, p 
value and anatomical location of the cluster. The canonical JHU corticospinal tract (blue) did not overlap with 
the cluster.  
90x50mm (300 x 300 DPI)  
 
 
Page 52 of 55
John Wiley & Sons, Inc.
Human Brain Mapping
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
  
 
 
Selected coronal, axial and sagittal sections in normalized MNI space of the canonical CST tract used in this 
study for wCST-LL calculations, illustrating it encompasses the CST fibers originating from the primary motor 
cortex leg area.  
90x50mm (300 x 300 DPI)  
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Supplemental Figure 2: Lesion overlap map with a minimum of 6 participants with lesion for each particular 
pixel (same presentation as Figure 1). The coloured area therefore represents the search volume for the 
VLSM analysis (see Methods).  
140x203mm (300 x 300 DPI)  
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Supplemental Figure 3: Power map from the lesion overlaps with the zero-thresholded corticospinal tract 
overlaid (blue). Note that the tract intersects close to the peak overlap. See Figure 1 for details regarding 
presentation. Power is represented as the probability of detecting an effect at the p<0.05 level  for the 
distribution of 50 lesions.  
103x77mm (300 x 300 DPI)  
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